ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,858Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 262

$899K Total Retail Price of All Prescriptions

Rank: 2 out of 262

543 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 15,269 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 892 786 1 2
FUROSEMIDE 556 521 2 4
METOPROLOL TARTRATE 528 501 3 8
PRAVASTATIN SODIUM 452 440 4 41
LISINOPRIL 428 422 5 3
SIMVASTATIN 426 398 6 1
AMLODIPINE BESYLATE 425 422 7 6
OMEPRAZOLE 424 374 8 5
METOPROLOL SUCCINATE 390 362 9 11
ATORVASTATIN CALCIUM 303 285 10 13
HYDROCHLOROTHIAZIDE 301 299 11 7
SERTRALINE HCL 290 290 12 14
TAMSULOSIN HCL 252 233 13 25
POTASSIUM CHLORIDE 249 247 14 10
ALENDRONATE SODIUM 244 236 15 21
HYDROCODONE-ACETAMINOPHEN 239 203 S3 16 15
POLYETHYLENE GLYCOL 3350 238 194 17 42
ATENOLOL 237 234 18 16
METFORMIN HCL 213 207 19 9
GABAPENTIN 189 136 20 19
MIRTAZAPINE 178 178 21 35
DONEPEZIL HCL 171 159 22 23
WARFARIN SODIUM 163 155 23 12
ALLOPURINOL 163 159 23 22
LOSARTAN POTASSIUM 160 144 25 17
CARVEDILOL 160 160 25 31
RISPERIDONE 158 139 27 50
CLOPIDOGREL 152 150 28 38
DIGOXIN 135 135 29 28
FAMOTIDINE 132 131 30 65
TRIAMTERENE-HCTZ 130 130 31 32
ADVAIR DISKUS 130 121 31 34
DOXAZOSIN MESYLATE 128 124 33 59
DIOVAN 126 126 34 47
BUDESONIDE 121 91 35 163
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 120 36 24
PAROXETINE HCL 119 104 37 56
TRAZODONE HCL 118 81 38 36
ISOSORBIDE MONONITRATE ER 114 114 39 33
OLANZAPINE 112 11 40 130
TRAMADOL HCL 110 98 41 18
PLAVIX 108 107 42 64
CRESTOR 105 94 43 30
SPIRIVA 104 91 44 61
AVODART 102 100 45 120
MELOXICAM 100 87 46 54
OXYBUTYNIN CHLORIDE ER 97 86 47 102
DIOVAN HCT 95 95 48 103
AMLODIPINE BESYLATE-BENAZEPRIL 92 91 49 81
NAMENDA 91 91 50 37
FELODIPINE ER 88 84 51 127
IPRATROPIUM-ALBUTEROL 87 74 52 113
BENAZEPRIL HCL 85 85 53 99
PREDNISONE 85 70 53 29
JANTOVEN 83 82 55 39
LOSARTAN-HYDROCHLOROTHIAZIDE 82 82 56 43
ZOLPIDEM TARTRATE 82 77 56 26
ZETIA 82 77 56 60
DICLOFENAC SODIUM 78 75 59 111
JANUVIA 75 67 60 104
CARBIDOPA-LEVODOPA 74 61 61 66
FLUTICASONE PROPIONATE 74 60 61 48
CITALOPRAM HBR 74 60 61 20
PROPRANOLOL HCL 70 58 64 82
DILTIAZEM 24HR ER 68 68 65 114
ENALAPRIL MALEATE 64 64 66 27
FENTANYL 63 62 S2 67 40
PANTOPRAZOLE SODIUM 63 51 67 52
GLIPIZIDE XL 62 62 69 87
DIVALPROEX SODIUM 62 42 69 117
CELEBREX 59 51 71 91
NEXIUM 59 51 71 57
FENOFIBRATE 57 57 73 77
QUETIAPINE FUMARATE 55 37 74 71
ESCITALOPRAM OXALATE 54 42 75 83
KLOR-CON M20 52 52 76 98
DETROL LA 52 52 76 76
CYMBALTA 52 48 76 67
PREMARIN 50 46 R 79 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.